Mixed messages from Pfizer-BioNTech on vaccine reduction

Pfizer-BioNTech is sending mixed messages about COVID-19 vaccine shipments to Canada, telling Ottawa there will be a delay in deliveries, despite the drug company ramping up its manufacturing capacity in Europe. David Akin reports.